Rallybio Corporation (RLYB)
After hours:
| Previous close | 1.9000 |
| Open | 1.9400 |
| Bid | 1.8200 x 400 |
| Ask | 1.8500 x 400 |
| Day's range | 1.8200 - 2.0000 |
| 52-week range | 1.2250 - 9.1400 |
| Volume | |
| Avg. volume | 1,606,383 |
| Market cap | 75.85M |
| Beta (5Y monthly) | -1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8400 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.00 |
Business WireRallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
NEW HAVEN, Conn., May 09, 2024--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today reported first quarter financial results for the period ended March 31, 2024 and provided an update on recent company developments.
Business WireRallybio to Present at the 2024 Citizens JMP Life Sciences Conference
NEW HAVEN, Conn., May 07, 2024--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Steve Uden, M.D., Chief Executive Officer of Rallybio, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024 at 11:30 a.m. ET in New York, NY.
Business WireFNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
NEW HAVEN, Conn., April 17, 2024--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced the presentation of results from a fetal and neonatal alloimmune thrombocytopenia (FNAIT) systematic literature review and meta-analysis at the Academy of Managed Care Pharmacy (AMCP) 2024 Annual Meeting, which is taking place in New Orleans
